These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15354737)

  • 1. Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases.
    Raspollini MR; Amunni G; Villanucci A; Baroni G; Taddei A; Taddei GL
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):127-31. PubMed ID: 15354737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
    Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
    Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray.
    Kim MJ
    J Korean Med Sci; 2005 Aug; 20(4):643-8. PubMed ID: 16100458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.
    Vang R; Gown AM; Wu LS; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
    Mod Pathol; 2006 Nov; 19(11):1421-8. PubMed ID: 16980943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM; Meir A; Sabo E
    Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
    Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of REG4 in ovarian mucinous tumors.
    Huang Q; Chen X; Lu W; Lai M; Lu B
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
    Meagher NS; Wang L; Rambau PF; Intermaggio MP; Huntsman DG; Wilkens LR; El-Bahrawy MA; Ness RB; Odunsi K; Steed H; Herpel E; Anglesio MS; Zhang B; Lambie N; Swerdlow AJ; Lubiński J; Vierkant RA; Goode EL; Menon U; Toloczko-Grabarek A; Oszurek O; Bilic S; Talhouk A; García-Closas M; Wang Q; Tan A; Farrell R; Kennedy CJ; Jimenez-Linan M; Sundfeldt K; Etter JL; Menkiszak J; Goodman MT; Klonowski P; Leung Y; Winham SJ; Moysich KB; Behrens S; Kluz T; Edwards RP; Gronwald J; Modugno F; Hernandez BY; Chow C; Kelemen LE; Keeney GL; Carney ME; Natanzon Y; Robertson G; Sharma R; Gayther SA; Alsop J; Luk H; Karpinskyj C; Campbell I; Sinn P; Gentry-Maharaj A; Coulson P; Chang-Claude J; Shah M; Widschwendter M; Tang K; Schoemaker MJ; Koziak JM; Cook LS; Brenton JD; Daley F; Kristjansdottir B; Mateoiu C; Larson MC; Harnett PR; Jung A; deFazio A; Gorringe KL; Pharoah PDP; Minoo P; Stewart C; Bathe OF; Gui X; Cohen P; Ramus SJ; Köbel M
    Mod Pathol; 2019 Dec; 32(12):1834-1846. PubMed ID: 31239549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive immunohistochemical profile of mucinous cystic neoplasms of pancreas, ovary and lung.
    Silverman JF; Zhu B; Liu Y; Lin X
    Histol Histopathol; 2009 Jan; 24(1):77-82. PubMed ID: 19012247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
    Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
    Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
    Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDX-2 immunostaining in primary and secondary ovarian carcinomas.
    Tornillo L; Moch H; Diener PA; Lugli A; Singer G
    J Clin Pathol; 2004 Jun; 57(6):641-3. PubMed ID: 15166272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas.
    Ji H; Isacson C; Seidman JD; Kurman RJ; Ronnett BM
    Int J Gynecol Pathol; 2002 Oct; 21(4):391-400. PubMed ID: 12352188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
    Raspollini MR; Nesi G; Baroni G; Girardi LR; Taddei GL
    Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):358-62. PubMed ID: 16280666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.
    Chou YY; Jeng YM; Kao HL; Chen T; Mao TL; Lin MC
    Histopathology; 2003 Aug; 43(2):151-6. PubMed ID: 12877730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression.
    Rossi G; Murer B; Cavazza A; Losi L; Natali P; Marchioni A; Migaldi M; Capitanio G; Brambilla E
    Am J Surg Pathol; 2004 Apr; 28(4):442-52. PubMed ID: 15087663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.